The NAILED stroke risk factor trial (Nurse based Age independent Intervention to Limit Evolution of Disease after stroke): Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Mooe, Thomas ^a,b   Bergström, Lisa ^b   Irewall, Anna Lotta ^a   Ögren, Joachim ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖSTERSUND HOSPITAL   (Sweden)

Author keywords

Cardiovascular diseases; Randomized controlled trial; Secondary prevention; Stroke

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CONTROLLED STUDY; FOLLOW UP; HUMAN; METABOLIC REGULATION; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SECONDARY PREVENTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; CLINICAL PROTOCOLS; DISEASE PROGRESSION; EXERCISE; HUMANS; HYPOLIPIDEMIC AGENTS; ISCHEMIC ATTACK, TRANSIENT; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871783233     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-5     Document Type: Article

References (14)

1. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011, 42(5):1489-1494. 10.1161/STROKEAHA.110.602615, 21454819.
2. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005, 36(12):2748-2755. 10.1161/01.STR.0000190118.02275.33, 16254218.
3. Rothwell PM, Algra A, Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischemic attack and ischemic stroke. Lancet 2011, 377(9778):1681-1692. 10.1016/S0140-6736(11)60516-3, 21571151.
4. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 2007, 38(6):1881-1885. 10.1161/STROKEAHA.106.475525, 17431209.
5. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2011, 42(1):227-276. 10.1161/STR.0b013e3181f7d043, 20966421.
6. MacKay-Lyons M, Thornton M, Ruggles T, Manley S. Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack (Protocol). Cochrane Database Syst Rev 2010, (Issue 9):CD008656.
7. Alvarez-Sabin J, Quintana M, Hernandez-Presa MA, Alvarez C, Chaves J, Ribo M. Therapeutic interventions and success in risk factor control for secondary prevention of stroke. J Stroke Cerebrovasc Dis 2009, 18(6):460-465. 10.1016/j.jstrokecerebrovasdis.2009.01.014, 19900649.
8. Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, Alberts MJ, Fagan SC, Fonarow GC, Johnston SC, et al. Secondary preventive medication persistence and adherence one year after stroke. Neurology 2011, 77(12):1182-1190. 10.1212/WNL.0b013e31822f0423, 3265047, 21900638.
9. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004, 35(12):2879-2883. 10.1161/01.STR.0000147967.49567.d6, 15514170.
10. Ross JS, Arling G, Ofner S, Roumie CL, Keyhani S, Williams LS, Ordin DL, Bravata DM. Correlation of inpatient and outpatient measures of stroke care quality within veterans health administration hospitals. Stroke 2011, 42(8):2269-2275. 10.1161/STROKEAHA.110.611913, 3144276, 21719771.
11. Adie K, James MA. Does telephone follow-up improve blood pressure after minor stroke or TIA?. Age Ageing 2010, 39(5):598-603. 10.1093/ageing/afq085, 20667838.
12. Schulz KF, Altman DG, Moher D, . Group C CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMC Med 2010, 8(1):18. 10.1186/1741-7015-8-18, 2860339, 20334633, Group C.
13. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009, 27(11):2121-2158. 10.1097/HJH.0b013e328333146d, 19838131.
14. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):E1-E40.